Skip to Content

What is the difference between Jornay PM and other once-daily methylphenidate formulations?

Answers (1)

Official Answer by Drugs.com 11 Sep 2018

The difference between Jornay PM (methylphenidate extended-release) and other once-daily methylphenidate formulations for attention deficit hyperactivity disorder (ADHD) is when they are taken. Jornay PM is approved for the treatment of attention deficit hyperactivity disorder (ADHD) in patients 6 years and older and is taken once-daily in the evening. Other once daily methylphenidate formulations are taken in the morning, and include:

  • Aptensio XR
  • Concerta
  • Cotempla XR-ODT
  • Metadate CD
  • QuilliChew ER
  • Quillivant XR
  • Ritalin LA

Timing of administration for Jornay PM is adjusted between 6:30 p.m. and 9:30 p.m. in the evening to optimize side effects and effectiveness the next morning and throughout the day. Jornay PM utilizes a unique methylphenidate delivery technology known as the Delexis platform that delays initial release of the drug for up to 10 hours and then controls release throughout the day. An advantage to this delayed-release mechanism is that it allows control over ADHD symptoms in children during the early morning routine, which remains a significant concern for parents.

Drugs.com free discount card

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

Is Xyosted a controlled substance?

Updated 13 days ago 1 answerFAQ by Drugs.com

What type of drug is Nuzyra (omadacycline)?

Updated 13 days ago 1 answerFAQ by Drugs.com

What is the Tegsedi REMS Program?

Updated 5 days ago 1 answerFAQ by Drugs.com

What condition is Revcovi used to treat?

Updated 5 days ago 1 answerFAQ by Drugs.com